Testing effectiveness (Phase 2)Ended earlyNCT03395340
What this trial is testing
Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD)
Who this might be right for
Graft Versus Host DiseaseJNS KinaseTopical Administration
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1